PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-04-17

Date Title Company
17-Apr-2023 Imvax Presents New Data at AACR 2023 Supporting the Mechanism of Action of its Lead Program, IGV-001, for Glioblastoma Businesswire
17-Apr-2023 FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis Businesswire
17-Apr-2023 Trefoil Therapeutics Announces TTHX1114 Data Presentations at the Annual Association for Research in Vision and Ophthalmology (ARVO) Meeting Businesswire
17-Apr-2023 Armis Announces Significant Business Momentum in Healthcare Businesswire
17-Apr-2023 PIC Therapeutics Presents Pre-Clinical Data Update on eIF4E Regulators at AACR Annual Meeting 2023 Businesswire
17-Apr-2023 Innoviva Stock Trading Halted Today Businesswire
17-Apr-2023 Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed Drägerwerk AG & Co. KGaA
17-Apr-2023 Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees and Opens Spring 2023 Submissions Businesswire
17-Apr-2023 Zymeworks To Host First Quarter 2023 Results Conference Call Businesswire
17-Apr-2023 GE HealthCare to Showcase Latest AI Innovations at HIMSS 2023 Businesswire
17-Apr-2023 Labster Announces Automatic User Experience Upgrade to its Virtual Science Lab Simulation EdTech Platform Businesswire
17-Apr-2023 ECCMID 2023: Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja® / Fetroja® (cefiderocol) Against Some of the Most Difficult-to-Treat Gram-Negative Bacterial Pathogens Businesswire
17-Apr-2023 Lundbeck to Present Broad Range of Data on Migraine and Brain Health at 75th Annual Meeting of the American Academy of Neurology Businesswire
17-Apr-2023 Armis Identifies the Riskiest Medical and IoT Devices in Clinical Environments Businesswire
17-Apr-2023 Cognito Therapeutics Announces Key Medical and Technology Leadership Appointments as Late-Stage Neurotechnology Platform Advances Businesswire
17-Apr-2023 Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023 Businesswire
17-Apr-2023 Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307 Businesswire
17-Apr-2023 Strand Therapeutics Presents Preclinical Data on Programmable mRNA Therapy STX-001 at AACR 2023 Businesswire
17-Apr-2023 Scientist.com Marketplace Expands to Include a Broad Selection of Ready-to-Use Life Science Reagents and Lab Supplies Businesswire
17-Apr-2023 Ambulatory Polysomnography (PSG) Systems Market is anticipated to reach US$ 516.9 million by 2032, at a CAGR of 5.2% | FMI MARKITWIRED